我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Drug Combination Strategy: Pharmacokinetics and Drug-Drug Interaction Considerations in Diseased Patients

Nuggehally R Srinivas

the supply of constant dose combinations (FDC) is still at the upward thrust on the grounds that they provide comfort and compliance for the sickness control. Given the involvement of polypharmacy inside the cutting-edge disease management for sure chronic illnesses, the development of more moderen FDC mixtures to advantage sufferers in a disease region is amply justified. A recent booklet in this critical subject matter lays out a method and framework for an unequivocal and impartial assessment of FDC product from a pharmacokinetic perspective. some key topics of debate on this paper includes the attributes that make a contribution for the dose choice of the character FDC drug additives and the key capabilities to determine the volume (or lack) of a pharmacokinetic drug-drug interaction among the 2 tablets in the FDC. The reason of this editorial is to provide a few perspectives at the altered changes in body structure in sickness sufferers which could probably have an influence at the pharmacokinetic disposition of medication which might be used inside the aggregate approach.